Alkem Laboratories informs about disclosure

07 Jan 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulations, Alkem Laboratories has informed that the Company has received an order passed by statutory authority under the Goods and Services Tax Act, 2017 and the details as required under Clause 20 of Para A of Part A of Schedule III of SEBI LODR Regulations read with Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure A. The Company is in the process of taking appropriate action(s), including but not limited to the filing of an appeal against the order. The above information is also available on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

4939.10 47.85 (0.98%)
03-Apr-2025 13:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...